Phase III, randomized, double‐blind, placebo‐controlled study to evaluate the efficacy and safety of teneligliptin monotherapy in Chinese patients with type 2 diabetes mellitus inadequately controlled with diet and exercise

Journal of Diabetes Investigation ◽

10.1111/jdi.13389 ◽

2020 ◽

Author(s):

Linong Ji ◽

Jianhua Ma ◽

Weiping Lu ◽

Jingdong Liu ◽

Jiao’e Zeng ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Phase Iii ◽

Chinese Patients ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Diet And Exercise

Download Full-text

Efficacy and safety of teneligliptin added to metformin in Chinese patients with type 2 diabetes mellitus inadequately controlled with metformin: A phase 3, randomized, double‐blind, placebo‐controlled study

Endocrinology Diabetes & Metabolism ◽

10.1002/edm2.222 ◽

2021 ◽

Author(s):

Linong Ji ◽

Ling Li ◽

Jianhua Ma ◽

Xuefeng Li ◽

Dongmei Li ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Chinese Patients ◽

Controlled Study ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and safety of teneligliptin, a novel dipeptidyl peptidase-4 inhibitor, in Korean patients with type 2 diabetes mellitus: a 24-week multicentre, randomized, double-blind, placebo-controlled phase III trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.12631 ◽

2016 ◽

Vol 18 (5) ◽

pp. 528-532 ◽

Cited By ~ 12

Author(s):

S. Hong ◽

C.-Y. Park ◽

K. A. Han ◽

C. H. Chung ◽

B. J. Ku ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Phase Iii Trial ◽

Double Blind Placebo ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text

Efficacy and safety of linagliptin as add‐on therapy to insulin in Chinese patients with type 2 diabetes mellitus: A randomized, double‐blind, placebo‐controlled trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.14231 ◽

2020 ◽

Author(s):

Wenying Yang ◽

Xiangjin Xu ◽

Tao Lei ◽

Jianhua Ma ◽

Ling Li ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Controlled Trial ◽

Chinese Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A randomized, double‐blind, placebo‐controlled study on long‐term efficacy and safety of ipragliflozin treatment in patients with type 2 diabetes mellitus and renal impairment: results of the Long‐Term ASP1941 Safety Evaluation in Patients with Type 2 Diabetes with Renal Impairment (LANTERN) study

Diabetes Obesity and Metabolism ◽

10.1111/dom.12403 ◽

2015 ◽

Vol 17 (2) ◽

pp. 152-160 ◽

Cited By ~ 69

Author(s):

A. Kashiwagi ◽

H. Takahashi ◽

H. Ishikawa ◽

S. Yoshida ◽

K. Kazuta ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Renal Impairment ◽

Safety Evaluation ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and safety of teneligliptin added to glimepiride in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled study with an open-label, long-term extension

Diabetes Obesity and Metabolism ◽

10.1111/dom.12235 ◽

2013 ◽

Vol 16 (5) ◽

pp. 418-425 ◽

Cited By ~ 32

Author(s):

T. Kadowaki ◽

K. Kondo

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Japanese Patients ◽

Controlled Study ◽

Efficacy And Safety ◽

Open Label ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and safety of fasiglifam ( TAK ‐875), a G protein‐coupled receptor 40 agonist, in J apanese patients with type 2 diabetes inadequately controlled by diet and exercise: a randomized, double‐blind, placebo‐controlled, phase III trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.12467 ◽

2015 ◽

Vol 17 (7) ◽

pp. 675-681 ◽

Cited By ~ 78

Author(s):

K. Kaku ◽

K. Enya ◽

R. Nakaya ◽

T. Ohira ◽

R. Matsuno

Keyword(s):

Type 2 Diabetes ◽

G Protein ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Phase Iii Trial ◽

Double Blind Placebo ◽

Diet And Exercise ◽

G Protein Coupled

Download Full-text

A randomized, double‐blind, placebo‐controlled, phase II clinical trial to investigate the efficacy and safety of oral DA‐1229 in patients with type 2 diabetes mellitus who have inadequate glycaemic control with diet and exercise

Diabetes/Metabolism Research and Reviews ◽

10.1002/dmrr.2613 ◽

2014 ◽

Vol 31 (3) ◽

pp. 295-306 ◽

Cited By ~ 25

Author(s):

Chang Hee Jung ◽

Cheol‐Young Park ◽

Kyu‐Joeng Ahn ◽

Nan‐Hee Kim ◽

Hak‐Chul Jang ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Clinical Trial ◽

Type 2 Diabetes Mellitus ◽

Glycaemic Control ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Diet And Exercise

Download Full-text

Efficacy and safety of canagliflozin monotherapy in Japanese patients with type 2 diabetes inadequately controlled with diet and exercise: a 24-week, randomized, double-blind, placebo-controlled, Phase III study

Expert Opinion on Pharmacotherapy ◽

10.1517/14656566.2014.935764 ◽

2014 ◽

Vol 15 (11) ◽

pp. 1501-1515 ◽

Cited By ~ 78

Author(s):

Nobuya Inagaki ◽

Kazuoki Kondo ◽

Toru Yoshinari ◽

Nahoko Takahashi ◽

Yutaka Susuta ◽

...

Keyword(s):

Type 2 Diabetes ◽

Japanese Patients ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Diet And Exercise ◽

Phase Iii Study

Download Full-text

Efficacy and safety of teneligliptin, a dipeptidyl peptidase‐4 inhibitor, combined with metformin in K orean patients with type 2 diabetes mellitus: a 16‐week, randomized, double‐blind, placebo‐controlled phase III trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.12424 ◽

2015 ◽

Vol 17 (3) ◽

pp. 309-312 ◽

Cited By ~ 22

Author(s):

M. K. Kim ◽

E.‐J. Rhee ◽

K. A. Han ◽

A. C. Woo ◽

M.‐K. Lee ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Phase Iii Trial ◽

Double Blind Placebo ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text

Efficacy and Safety of Linagliptin in Subjects With Long-standing Type 2 Diabetes Mellitus (>10 Years): Evidence From Pooled Data of Randomized, Double-blind, Placebo-controlled, Phase III Trials

Clinical Therapeutics ◽

10.1016/j.clinthera.2014.07.020 ◽

2014 ◽

Vol 36 (11) ◽

pp. 1595-1605 ◽

Cited By ~ 11

Author(s):

Rosemarie Lajara ◽

Richard Aguilar ◽

Uwe Hehnke ◽

Hans-Juergen Woerle ◽

Maximilian von Eynatten

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Pooled Data ◽

Phase Iii Trials

Download Full-text